IP Library Assignment 065153/0953
Patent Assignment
Reel/Frame 065153/0953

Release of Security Interest

Recorded: 2023-10-06 Pages: 8
Assignor
CITIBANK, N.A.
Executed: 2023-10-06
Assignees
HORIZON THERAPEUTICS IRELAND DAC (FKA HORIZON PHARMA IRELAND LIMITED)
70 ST. STEPHEN'S GREEN, DUBLIN 2, D02 E2X4, IRELAND
HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
HZNP LIMITED
70 ST. STEPHEN'S GREEN, DUBLIN 2, D02 E2X4, ICELAND
Covered Properties (28)
Treatment of Abnormal Increases in Gastrointestinal Motility with (R)-Verapamil
Patent: 6,849,661 →
Application: 10/294,692 →
Publication: US 2004/0063784
Methods and medicaments for administration of ibuprofen
Application: 11/489,269 →
Publication: US 2008/0021078
Unit dose form for administration of ibuprofen
Application: 11/489,272 →
Publication: US 2008/0020040
Methods and Medicaments for Administration of Ibuprofen
Patent: 8,067,451 →
Application: 11/779,204 →
Publication: US 2008/0063706
Diclofenac Topical Formulation
Patent: 8,252,838 →
Application: 12/134,121 →
Publication: US 2008/0300311
Stable Compositions of Famotidine and Ibuprofen
Patent: 8,067,033 →
Application: 12/324,808 →
Publication: US 2009/0142393
Treatment of pain with topical diclofenac compounds
Patent: 8,546,450 →
Application: 12/459,998 →
Methods and Medicaments for Administration of Ibuprofen
Application: 12/491,199 →
Publication: US 2009/0264484
Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof
Patent: 9,220,698 →
Application: 12/553,107 →
Publication: US 2010/0062064
Treatment of pain with topical diclofenac compounds
Patent: 8,618,164 →
Application: 12/660,865 →
Publication: US 2013/0041034
Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer
Patent: 8,945,621 →
Application: 12/822,612 →
Publication: US 2010/0330179
Treatment of Pain with Topical Diclofenac
Patent: 8,217,078 →
Application: 12/914,867 →
Stable Compositions of Famotidine and Ibuprofen
Patent: 8,309,127 →
Application: 13/403,923 →
Publication: US 2012/0156291
Stable Compositions of Famotidine and Ibuprofen
Patent: 8,318,202 →
Application: 13/403,930 →
Publication: US 2012/0156292
METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Patent: 9,040,591 →
Application: 13/553,453 →
Publication: US 2013/0030057
Diclofenac Topical Formulation
Patent: 8,563,613 →
Application: 13/564,688 →
Publication: US 2012/0295978
Stable Compositions of Famotidine and Ibuprofen
Patent: 8,501,228 →
Application: 13/620,141 →
Publication: US 2013/0011475
Stable Compositions of Famotidine and Ibuprofen
Patent: 8,449,910 →
Application: 13/620,150 →
Publication: US 2013/0011476
Dispensing System
Application: 13/657,711 →
Publication: US 2014/0113970
Treatment of Pain with Topical Diclofenac
Patent: 9,132,110 →
Application: 13/665,790 →
Publication: US 2013/0065870
Treatment of Pain with Topical Diclofenac
Patent: 8,741,956 →
Application: 13/668,061 →
Publication: US 2013/0059915
Methods and Medicaments for Administration of Ibuprofen
Application: 13/758,821 →
Publication: US 2014/0017321
Medicaments Containing Famotidine and Ibuprofen and Administration of Same
Application: 13/769,196 →
Publication: US 2014/0066485
Pharmaceutical Compositions of Ibuprofen and Famotidine
Application: 13/849,213 →
Publication: US 2013/0236538
Stable Compositions of Famotidine and Ibuprofen
Application: 13/959,924 →
Publication: US 2014/0186439
Diclofenac Topical Formulation
Patent: 8,871,809 →
Application: 14/025,781 →
Publication: US 2014/0018427
Pharmaceutical Compositions of Ibuprofen and an H2 Receptor Antagonist
Application: 14/090,084 →
Publication: US 2014/0322313
Diclofenac Topical Formulation
Patent: 9,066,913 →
Application: 14/497,096 →
Publication: US 2015/0011635
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 19, 2009
From: XU, JERRY; TIDMARSH, GEORGE
To: HORIZON THERAPEUTICS, INC.
Reel/Frame 022285/0868 →
Assignment of Assignor's Interest Nov 17, 2009
From: SINGH, JAGAT; SHAINHOUSE, JOSEPH ZEV; GALER, BRADLEY S.; KING-SMITH, ROBERT DOMINIC
To: NUVO RESEARCH INC.
Reel/Frame 023532/0012 →
Assignment of Assignor's Interest Feb 24, 2010
From: ORLEMANS, EVERARDUS; PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 023987/0300 →
Assignment of Assignor's Interest Feb 24, 2010
From: ASTRAZENECA UK LIMITED
To: POZEN INC.
Reel/Frame 023987/0309 →
Assignment of Assignor's Interest Feb 24, 2010
From: POZEN INC.
To: ASTRAZENECA UK LIMITED
Reel/Frame 023987/0313 →
Assignment of Assignor's Interest Feb 24, 2010
From: AULT, BRIAN; SOSTEK, MARK
To: ASTRAZENECA R&D WILMINGTON
Reel/Frame 023987/0290 →
Assignment of Assignor's Interest Feb 24, 2010
From: ASTRAZENECA PHARMACEUTICALS LP
To: ASTRAZENECA UK LIMITED
Reel/Frame 023987/0303 →
Change of Name Aug 5, 2010
From: HORIZON THERAPEUTICS, INC.
To: HORIZON PHARMA USA, INC.
Reel/Frame 024798/0016 →
Corrective Assignment to Correct the Receiving Party Name Should Be Astrazeneca Pharmaceuticals Lp Previously Recorded on Reel 023987 Frame 0290. Assignor(S) Hereby Confirms the Receiving Party Name Should Be Changed from Astrazeneca R&D Wilmington to Astrazeneca Pharmaceuticals Lp. Feb 16, 2011
From: AULT, BRIAN; SOSTEK, MARK
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 025810/0644 →
Assignment of Assignor's Interest Oct 3, 2011
From: SINGH, JAGAT; SHAINHOUSE, JOSEPH ZEV; GALER, BRADLEY S.; KING-SMITH, ROBERT DOMINIC
To: NUVO RESEARCH INC.
Reel/Frame 027008/0416 →
Patent Security Agreement Feb 29, 2012
From: HORIZON PHARMA USA, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC
Reel/Frame 027784/0378 →
Change of Name Jun 19, 2012
From: AGI THERAPEUTICS RESEARCH LIMITED
To: VIDARA THERAPEUTICS RESEARCH LIMITED
Reel/Frame 028401/0563 →
Security Agreement Jun 19, 2012
From: AGI THERAPEUTICS PUBLIC LIMITED COMPANY; VIDARA THERAPEUTICS RESEARCH LIMITED
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028401/0688 →
Change of Name Jun 19, 2012
From: AGI THERAPEUTICS LIMITED
To: AGI THERAPEUTICS PUBLIC LIMITED COMPANY
Reel/Frame 028401/0655 →
Assignment of Assignor's Interest Jun 27, 2012
From: SINGH, JAGAT; SHAINHOUSE, JOSEPH ZEV; GALER, BRADLEY S.; KING-SMITH, ROBERT DOMINIC
To: NUVO RESEARCH INC.
Reel/Frame 028452/0009 →
Corrective Assignment to Correct the Assignee's Name from Nuvo Research to Nuvo Research Inc. Previously Recorded on Reel 021309 Frame 0825. Assignor(S) Hereby Confirms the Assignment of Assignors' Entire Interest in and to the Invention and Application to Nuvo Research Inc. Jun 28, 2012
From: KISAK, ED; SINGH, JAGAT
To: NUVO RESEARCH INC.
Reel/Frame 028466/0243 →
General Security Agreement Aug 20, 2012
From: NUVO RESEARCH INC.
To: PALADIN LABS INC.
Reel/Frame 028816/0225 →
Assignment of Assignor's Interest Aug 28, 2012
From: ASTRAZENECA UK LIMITED
To: ASTRAZENECA AB
Reel/Frame 028860/0990 →
Assignment of Assignor's Interest Aug 28, 2012
From: AULT, BRIAN; HWANG, CLARA; SOSTEK, MARK
To: ASTRAZENECA PLP
Reel/Frame 028860/0759 →
Assignment of Assignor's Interest Aug 28, 2012
From: ASTRAZENECA PHARMACEUTICALS LP
To: ASTRAZENECA UK LIMITED
Reel/Frame 028860/0940 →
Assignment of Assignor's Interest Aug 28, 2012
From: ORLEMANS, EVERARDUS; PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 028860/0880 →
Assignment of Assignor's Interest Aug 28, 2012
From: POZEN INC.
To: ASTRAZENECA AB
Reel/Frame 028861/0035 →
Assignment of Assignor's Interest Aug 28, 2012
From: ASTRAZENECA AB
To: ASTRAZENECA AB; POZEN INC.
Reel/Frame 028861/0066 →
Assignment of Assignor's Interest Oct 11, 2012
From: ASTRAZENECA UK LIMITED; POZEN INC.
To: ASTRAZENECA AB
Reel/Frame 029113/0459 →
Assignment of Assignor's Interest Dec 13, 2012
From: DESAI, TEJAS; VO, NGOC TRUC-CHI
To: NUVO RESEARCH INC.
Reel/Frame 029466/0637 →